Showing results (221-230 of 435) with videos related to

Sort By:
Pageof 44
Acta Oncologica (Stockholm, Sweden)|June 30, 2010
The interface of population-based cancer registries and biobanks in etiological and clinical research--current and future perspectivesKristin Andersson, Freddie Bray, Marc Arbyn, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
Exploration of Patient-Derived Pancreatic Ductal Adenocarcinoma Ex Vivo Tissue for Treatment ResponseTímea Szekerczés, Arun Kumar Selvam, Carlos Fernández Moro, et al.
British Journal of Cancer|October 23, 2018
Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based studyLaila Sara Arroyo-Mühr, Camilla Lagheden, Emilie Hultin, et al.
Plos One|March 4, 2017
Viruses in case series of tumors: Consistent presence in different cancers in the same subjectLaila Sara Arroyo Mühr, Maria Hortlund, Zurab Bzhalava, et al.
International Journal of Cancer|January 19, 2026
Predicting optimal impact interventions in the post-HPV vaccination worldMatti Lehtinen, Marc Lipsitch, Ville N Pimenoff, et al.
Plos One|May 27, 2016
Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control StudyVitaly Smelov, Tarik Gheit, Karin Sundström, et al.
Genome Medicine|October 18, 2022
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancerJames E Barrett, Karin Sundström, Allison Jones, et al.
Plos Medicine|August 23, 2021
Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trialK Miriam Elfström, Carina Eklund, Helena Lamin, et al.
BMJ (Clinical Research Ed.)|February 25, 2026
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based studyShiqiang Wu, Yunyang Deng, Tiia Lepp, et al.
The Journal of General Virology|December 2, 1999
Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesisIlvars Silins, Zhaohui Wang, Elisabeth Åvall-Lundqvist, et al.
Pageof 44